An analysis of preoperatively HE4 and CA125 in matched samples of patients (pts) with benign disease and borderline ovarian tumors (BOT) with and without invasive implants (InvImp).

免费注册

科研之友

微信

新浪微博

Facebook

作者：Nassir Mani; Braicu Elena Ioana; Richter Rolf; Chekerov Radoslav; van Gorp Loon; Timmerman Dirk; Vergote Ignace; Sehouli Jalid

来源：49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2013-05-31 to 2013-06-04.

更新时间：2018-01-19 14:01

科研之友科研之友机构版科创云

科研成果科研人员科研机构

帮助中心隐私政策服务条款

在线客服：【立即咨询】客户热线：400-1616-289 电子邮箱：support@scholarmate.com

微信公众号